COMORBILITATS i ENVELLIMENT
|
|
- Lorena Millicent Nash
- 5 years ago
- Views:
Transcription
1 COMORBILITATS i ENVELLIMENT EN PACIENTS AMB INFECCIÓ PEL VIH Eugènia Negredo Fundació Lluita contra la Sida Hospital Universitari Germans Trias i Pujol Badalona Gener 2016
2 SURVIVAL FOR HIV INFECTED PATIENTS
3 COMORBIDITIES AND RISK FACTORS THE PATIENT Individual and social factors: Higher rate of tradi=onal risk factors: smoking, dyslipidemia, HTN, diabetes Gene=c factors ComorbidiFes THE VIRUS HIV infec=on itself Ongoing inflamma=on despite HAART THE TREATMENT An=retroviral therapy and toxicity
4 CAUSES OF INCREASED COMORBIDITIES Low CD4+ T- cell nadir Persistent inflammafon CoinfecFons (hepaffs, CMV, EBV, and HPV) Increased comorbidifes Lifestyle (smoking, etc) CumulaFve cart exposure Aging Adapted from Deeks SG, et al. BMJ. 2009;338:a3172. Operskalski EA. Curr HIV/AIDS Rep. 2011;8:12-22.
5 CAUSES OF INCREASED COMORBIDITIES: 1. INFLAMMATION
6 CAUSES OF INFLAMMATION
7 CAUSES OF INFLAMMATION Deeks et al. Annual Review of Medicine 2011.
8 Plasma concentrafon of hscrp (ng/ml) CAUSES OF INCREASED COMORBIDITIES: 1. INFLAMMATION Markers of inflammafon may persist at elevated levels despite ART 40,000 35,000 30,000 25,000 20,000 15,000 10,000 5,000 0 HIV uninfected N=115 HIV- infected pafents N=30 HIV- uninfected matched controls * HIV infected, untreated HIV infected, 3 months of ART HIV infected, 12 months of ART * P<0.001 vs HIV uninfected ** P<0.001 vs HIV infected, untreated Adapted from Kristoffersen US, et al. 15th CROI 2008; Poster 953. **
9 CAUSES OF INFLAMMATION Deeks et al. Annual Review of Medicine 2011.
10 115 CONSEQUENCES OF INFLAMMATION Arterial inflammation as measured by PET-scan: Increased in HIV-infected patients as compared to VIH negative subjects with the same FRS Subramanian S, JAMA 2012
11 CONSEQUENCES OF INFLAMMATION InflammaFon Predicts Disease in Treated HIV InfecFon Cardiovascular Disease (Duprez, Atherosclerosis 2009) Cancer (Breen, Cancer Epi Bio Prev 2010; Borges, AIDS 2013) Venous Thromboembolism (Musselwhite, AIDS 2011) Type II Diabetes (Brown, Diabetes Care 2010) CogniFve DysfuncFon (Burdo, AIDS 2013; Letendre CROI 2012, Abs#82) Frailty (Erlandson, JID 2013) Mortality (Kuller, PLoS Med 2008; Tien, JAIDS, 2010; Jus=ce, CID 2012)
12 CONSEQUENCES OF INFLAMMATION
13 CAUSES OF INCREASED COMORBIDITIES: 1. INFLAMMATION ART HIV - INFLAMMATION Heart disease Kidney disease Liver disease Osteoporosis Cancer Cognitive declines A strong acute-phase inflammatory response was required for survival; however, inflammatory responses can also promote chronic diseases. COMORBIDITIES Adapted from Vance DE. Am J Nurs 2010
14 CAUSES OF INCREASED COMORBIDITIES: 2. AGING 25% 20% % 10% 5% 0% CDC HIV Surveillance Report 2004 and Luther VP. Clin Geriatr Med. 2007;23:
15 AGING From Wikipedia Ageing (Bri=sh English) or aging (American English) is the process of becoming older. In humans, ageing represents the accumula=on of changes in a human being over =me, encompassing physical, psychological, and social change.
16 AGING InflammaFon Hypothesis of Aging supports the molecular basis of the inflammatory process as a plausible cause of the aging process
17 INFLAMMAGING The aging immune system is characterized by a low level chronic systemic inflammatory state, termed InflammAging. This inflammatory phenotype is marked by elevated circula=ng levels of markers of: - Inflamma=on (e.g., C- reac=ve protein (CRP) - Pro- inflammatory cytokines (interleukin- 6 (IL- 6) and tumor necrosis factor- α (TNF- α)) It is associated with increased morbidity and mortality in older adults - Franceschi C, et al. Inflamm- aging. An evolu=onary perspec=ve on immunosenescence. Ann N YAcad Sci. 2000;908: De Mar=nis Met al. Inflamma=on markers predic=ng frailty and mortality in the elderly. Exp Mol Pathol. 2006;80(3): Roubenoff R, et al. Cytokines, insulin- like growth factor 1, sarcopenia, and mortality in very old community- dwelling men and women: the Framingham Heart Study. Am J Med. 2003;115(6):
18 IMMUNESENESCENCE Thymic atrophy Decreased bone marrow produc=on Decreased B and T cell ac=va=on and matura=on resul=ng in decreased humoral and cell- mediated immunity (naïve and memory cells). Increased frequency and severity of diseases such as chronic inflammafon disorders (neurodegenerafve, cardiovascular ) and autoimmunity And major suscepfbility to cancers and infecfons
19 IMMUNESENESCENCE
20 HIV and AGING
21 PHYSIOLOGICAL PROCESS OF AGING Immunosenescence Lower pulmonary capacity Brain atrophy, decreased cerebral blood flow, decrease in neurotransmitter concentrations Thyroid atrophy, adrenal glands atrophy, alterations in carbohydrate, and lipid metabolism Lower gastrointestinal motility, lower hepatic blood flow, lower gastrointestinal immunity Decreased elasticity, alterations in the heart Decreased glomerular filtration rate Lower bone density Muscle atrophy, alterations in the modulation of electrolyte
22 CLINICAL CONSEQUENCES OF AGING Fulop et al. Clinical interven=ons in aging 2007.
23 CONSEQUENCES OF VIH/INFLAMMATION and AGING ART HIV - INFLAMMATION Heart disease Kidney disease Liver disease Osteoporosis Cancer Cognitive declines AGING Heart disease Kidney disease Liver disease Osteoporosis Cancer Cognitive declines Adapted from Vance DE. Am J Nurs 2010
24 CAUSES OF INCREASED COMORBIDITIES: 2. AGING ART Accumulation HIV - INFLAMMATION of changes in a Heart disease Kidney disease Liver disease Osteoporosis Cancer Cognitive declines human being over time AGING Heart disease Kidney disease Liver disease Osteoporosis Cancer Cognitive declines AGING Adapted from Vance DE. Am J Nurs 2010
25 AGING Accentuated Is aging an accentuated process in HIV people? Pathai S et al. J Gerontol A Biol Sci Med Sci 2014
26 ACCENTUATED AGING Overall and age-specific incidence rates Outcome Adjusted Mean Difference in Age (years) Risk airr (95% CI) Myocardial infarction (-0.62 to 0.54) 1.81 ( ) End stage renal disease (-0.69 to 0.23) 1.43 ( ) HIV-associated cancers (-0.93 to -0.21) 1.84 ( ) Other cancers (-0.78 to -0.12) 0.95 ( ) Althoff KN et al. Clin Infect Dis 2014
27 ACCENTUATED AGING Hasse B. et al. Clin Infect Dis ;
28 FRAILTY SYNDROME Frailty is a dis=nct clinical en=ty, differing from: - Comorbidity as defined by the presence of 2 diseases. - Disability as measured by impairment in ac=vi=es of daily living (ADL) The frailty phenotype in older adults consists of three or more of the following: - Weakness (measured by grip strength), - Low physical ac=vity, - Slowed motor performance (measured by walking speed), - Exhaus=on, and - Uninten=onal weight loss.
29 FRAILTY SYNDROME Frailty is recognized as an important clinical syndrome in old age, which: - Results from age- related declines in physiologic reserve and complexity in res=ng dynamics involving mul=ple physiologic systems, - Manifests by maladapfve responses to every day or acute stressors, and - Leads to a vicious cycle towards func=onal decline and other serious adverse health outcomes. This chronic condi=on is commonly described by two conceptual models: - the phenotype model (frailty syndrome) - the cumula=ve deficit model (frailty index). It has not been validated in HIV- infected popula=ons.
30 FRAILTY PHENOTYPE Predicts a number of serious adverse health outcomes in community- dwelling older adults, including: - acute illness, - falls, - cogni=ve decline, - hospitaliza=on, - disability, - dependency, and - mortality, adjus=ng for comorbidi=es.
31 FRAILTY PHENOTYPE in HIV In the Mul=center AIDS Cohort Study: - A frailty- related phenotype of weight loss, exhaus=on, slowness, and low physical ac=vity was more common in enrollees with HIV infec=on compared with those who did not have HIV infec=on, - It predicted mortality independently of CD4 T- lymphocyte count and viral load. Desquilbet L, et al. J Gerontol A Biol Sci Med Sci, 2007.
32 FRAILTY PHENOTYPE in HIV
33 FRAILTY PHENOTYPE in HIV Factors that have been associated with frailty in HIV+ populafons include: - age, - lower current or nadir CD4 T cell counts and - other HIV- infec=on- related inflamma=on, - hepa==s C co- infec=on, - other comorbidi=es, - depressive symptoms, and - certain social factors (e.g., lower educa=on, unemployment) Desquilbet L, et al. HIV- 1 infec=on is associated with an earlier occurrence of a phenotype related to frailty. J Gerontol A Biol Sci Med Sci. 2007;62: Piggou DA, et al. Frailty, HIVinfec=on, and mortality in an aging cohort of injec=on drug users. PLoS ONE. 2013;8(1):e Terzian AS, et al. Factors associated with preclinical disability and frailty among HIV- infected and HIV- uninfected women in the era of cart. J Womens Health (Larchmt). 2009;18(12):
34 AGING Accentuated Accelerated??? Is aging an accelerated process in HIV people? Pathai S et al. J Gerontol A Biol Sci Med Sci 2014
35 ACCELERATED AGING A prospecfve comparafve cohort study Prevalence and incidence of age- associated non- communicable comorbidi=es (AANCC) and their risk factors in persons 45 yrs Started October 2010 Par=cipants: ü HIV- 1- infected: from the HIV outpa=ent clinic at the Academic Medical Center (Amsterdam) ü HIV- 1- uninfected: from the Amsterdam Public Health Service sexual health clinic, and the ongoing Amsterdam Cohort Studies on HIV/AIDS
36 HIV neg (n=524) HIV pos (n=540) p-value Age (years) 52.1 ( ) 52.9 ( ) 0.20 Male gender 85.1% 88.1% 0.15 Dutch 81.3% 72.2% <0.001 MSM 69.7% 73.9% Time since HIV-1 diagnosis (yrs) 12.1 ( ) Mean CD4 count at enrollment (cells/mm 3 ) 565 ( ) Nadir CD4 count (cells/mm 3 ) 180 (78-260) Viral load > 200 at or within 4 mos prior to enrolment among cart-treated participants 1.5% Prior clinical AIDS 31.3% On cart 95.7% 79.1% started R x -naive 20.9% started ART-exp. Years since ART was first initiated (yrs) 10.4 ( ) Duration of viral load < 200 (since last > 200) (yrs) 5.8 ( ) Known cumulative duration CD4 < 200(mos) 0.8 ( ) Data presented as median (IQR) or percentage as appropriate. P-value represents Wilcoxon Rank Sum or Chi2 as appropriate Schouten J et al. Clin Infect Dis. 2014
37 Comorbidity risk factors HIV neg (n=524) HIV pos (n=540) Smoking status currently / ever (%) 24.6 / 38.9% 32.0 / 35.0% p-value / 0.23 Smoking (packyears, smokers only) 15.0 ( ) 22.2 ( ) <0.001 Severe alcohol use 7.3% 4.8% Daily to monthly use of: cannabis cocaine ecstasy 11.6% 2.9% 8.6% 13.5% 3.7% 4.3% BMI (kg/m 2 ) 24.5 ( ) 24.2 ( ) Blood pressure systolic (mmhg) 133 ( ) 135 ( ) Blood pressure diastolic (mmhg) 79 (72-85) 81 (75-89) <0.001 Data presented as median (IQR) or percentage as appropriate. P-value represents Wilcoxon Rank Sum or Chi2 as appropriate Schouten J et al. Clin Infect Dis. 2014
38 Age-associated Noncommunicable Comorbidity Prevalence HIV neg (n=524) HIV pos (n=540) p-value 1 AANCC* (%) 61.8% 69.4% Number of AANCC (mean (SD) 1.0 (0.95) 1.3 (1.14) <0.001 Schouten J et al. Clin Infect Dis. 2014
39 Comorbidity in relation to age Schouten J et al. Clin Infect Dis. 2014
40 Frailty 10.6% 50.7% 2.7% 36.3% Risk factors for (pre- )frailty Age Smoking Higher waist- to- hip ra=o Chronic hepa==s C HIV infec=on HIV- infected par=cipants (Historic) BMI <20 kg/m 2 frail pre- frail robust K.Kooij et al; AIDS (in press)
41 Frailty More frailty and pre- frailty at any age in HIV+ parfcipants HIV- HIV+ HIV- HIV+ HIV- HIV+ HIV- HIV+ HIV- HIV+ K.Kooij et al; AIDS (in press)
42 Comorbidity in relation to age Schouten J et al. Clin Infect Dis. 2014
43 Comparative risk of hypertension, diabetes mellitus, renal failure, cardiovascular disease, and fracture, by age, among patients versus control subjects. Guaraldi et al. Clin Infect Dis. 2011;53:
44 VIH, INFLAMMATION and AGING INFLAMMATION HIV AGING Comorbidi=es Frailty
45 SURVIVAL FOR HIV INFECTED PATIENTS Population group control HIV+ only 0.6 HIV+ with HIV risk factors 0.4 HIV+ with comorbidity Years HIV+ with alcohol/drug abuse Based on Obel N et al. Plos One 2011
46 GRACIAS HUGTP Guumann ICO Badalona IrsiCaixa FLS IGTP BST IMPPC FJC Universitat Autònoma de Barcelona Can Ruti campus, Badalona, Catalonia
HIV, Aging, and Frailty: Cannonball?
HIV, Aging, and Frailty: Cannonball? Keri Althoff, PhD, MPH Assistant Professor Co-Director, NA-ACCORD Epidemiology/Biostatistics Core kalthoff@jhsph.edu Disclosures None Funding KN Althoff is supported
More informationSituación actual de los pacientes VIH+ Esteban Martínez Hospital Clínic Barcelona
Situación actual de los pacientes VIH+ Esteban Martínez Hospital Clínic Barcelona Mortality per 1 patient-years HIV infection has changed from a fatal disease into a chronic condition This means long-term
More informationNo Conflict of Interest
No Conflict of Interest Aging and HIV Co-Morbidities: A Challenge for Engagement in Care Maria L Alcaide M.D. Division of Infectious Diseases University of Miami Miller School of Medicine Objectives Understand
More informationHIV, Co-morbidity and Ageing
HIV, Co-morbidity and Ageing A good head and a good heart are always a formidable combination V Encuentro de Salud Pública 8 October 2015, Madrid, Spain Peter Reiss Director HIV Monitoring Foundation Professor
More informationFrailty Predicts Recurrent but Not Single Falls 10 Years Later in HIV+ and HIV- Women
Frailty Predicts Recurrent but Not Single Falls 10 Years Later in HIV+ and HIV- Women Anjali Sharma, Deborah Gustafson, Donald R Hoover, Qiuhu Shi, Michael W Plankey, Phyllis C Tien, Kathleen Weber, Michael
More informationImmune Activation: Impact on Outcomes Peter W. Hunt, MD. Associate Professor of Medicine University of California San Francisco
Immune Activation: Impact on Outcomes Peter W. Hunt, MD Associate Professor of Medicine University of California San Francisco 10y Decreased Life Expectancy in Older HIV+ Adults in Modern ART Era ~9y shorter
More informationHIV, Multimorbidity, and Frailty: what s going on? (with apologies to Marvin Gaye)
HIV, Multimorbidity, and Frailty: what s going on? (with apologies to Marvin Gaye) Julian Falutz MD, FRCPC Director Comprehensive HIV Aging Initiative Chronic Viral Illness Service Senior Physician, Division
More informationNew Insights in Pathogenesis Inflammation and Immune Activation
Activity Code TM809 New Insights in Pathogenesis Inflammation and Immune Activation Turner Overton, M.D. Associate Professor of Medicine University of Alabama at Birmingham Learning Objectives Upon completion
More informationPrevalence of Comorbidities among HIV-positive patients in Taiwan
Prevalence of Comorbidities among HIV-positive patients in Taiwan Chien-Ching Hung, MD, PhD Department of Internal Medicine National Taiwan University Hospital, Taipei, Taiwan % of participants Comorbidity
More informationFrailty and HIV: what is the evidence? Giovanni Guaraldi
Frailty and HIV: what is the evidence? Giovanni Guaraldi Disclosure Dr Guaraldi has served as a consultant for Bristol-Myers Squibb, Abbvie, Theratecnologies, Gilead Sciences, Inc, GlaxoSmithKline, Merck
More informationHIV/HCV co-infected patients should be prioritised for HCV treatment. Sanjay Bhagani Royal Free Hospital/UCL London
HIV/HCV co-infected patients should be prioritised for HCV treatment Sanjay Bhagani Royal Free Hospital/UCL London Also requires other resources What should a prioritisation process Life-saving at this
More informationNational Council on Aging
National Council on Aging Engaging HIV+ Older Adults in Chronic Disease Self-Management Education July 19, 2016 Dr. Stephen E. Karpiak, ACRIA, Center on HIV and Aging Dr. Kate Lorig, Stanford Patient Education
More informationPhysical Function & Frailty in HIV
Physical Function & Frailty in HIV Kristine M. Erlandson, MD Assistant Professor University of Colorado Divisions of Infectious Diseases & Geriatric Medicine Research funding through the National Institutes
More informationIncreased and accelerated age-related complications in HIV-infected patients
Increased and accelerated age-related complications in HIV-infected patients Giovanni Guaraldi Università di Modena THE CHANGING SPECTRUM OF HIV CARE Pre- HAART 1996 Early- HAART 2005 Late- HAART Opportunistic
More informationDr Paddy Mallon. Mater Misericordiae University Hospital, Dublin, Ireland. BHIVA AUTUMN CONFERENCE 2014 Including CHIVA Parallel Sessions
BHIVA AUTUMN CONFERENCE 2014 Including CHIVA Parallel Sessions Dr Paddy Mallon Mater Misericordiae University Hospital, Dublin, Ireland 9-10 October 2014, Queen Elizabeth II Conference Centre, London BHIVA
More informationDispelling the myths: HIV, ageing and the changing causes of morbidity Caroline A Sabin
Dispelling the myths: HIV, ageing and the changing causes of morbidity Caroline A Sabin Centre for Clinical Research, Epidemiology, Modelling and Evaluation (CREME), UCL, London, UK Disclosures I have
More informationIntroduction to HIV and Aging
Introduction to HIV and Aging Sheree Starrett MD Medical Director - Rivington House June 27, 2008 Rivington House Objectives Know the demographics of aging and HIV Identify the similarities between aging
More informationFrailty and the Risk of Falls in HIV- Infected Older Adults in the ACTG A5322 Study
Frailty and the Risk of Falls in HIV- Infected Older Adults in the ACTG A5322 Study Katherine Tassiopoulos, Mona Abdo, Susan L. Koletar, Frank Palella, Babafemi Taiwo, and Kristine M. Erlandson for the
More informationPIs are the real world answer for the chronic patient s management. Giovanni Guaraldi
PIs are the real world answer for the chronic patient s management Giovanni Guaraldi HIV MEDICATION TOXICITY Ageing with HIV: The clinical consequences AGEING Heart disease Kidney disease Liver disease
More informationEndocrinopathy and Leukocyte Telomere Length in HIV+ Individuals in the CARMA Cohort
Endocrinopathy and Leukocyte Telomere Length in HIV+ Individuals in the CARMA Cohort Kristen M. Sokalski, Alice Mai, Jackson Chu, Hélène Côté, Evelyn J. Maan, Arianne Albert, Neora Pick, Deborah Money,
More informationClinical Epidemiology of Frailty in HIV Infection. Joseph B. Margolick, MD, PhD Johns Hopkins Bloomberg School of Public Health
Clinical Epidemiology of Frailty in HIV Infection Joseph B. Margolick, MD, PhD Johns Hopkins Bloomberg School of Public Health HIV and Aging 4 Similarities between HIV and aging at the biological level
More informationFrailty in Older Adults. Farshad Sharifi, MD, MPH Elderly Health Research Center
Frailty in Older Adults Farshad Sharifi, MD, MPH Elderly Health Research Center 1 Outlines Definition of frailty Significance of frailty Conceptual Frailty Models Pathogenesis of frailty Management of
More information11/18/17. HIV and Aging. HIV and Frailty. Frailty. Mechanism of FuncEonal Decline: Role for Frailty in HIV and Aging
Mechanism of FuncEonal Decline: Role for Frailty in HIV and Aging Alan Landay, PhD Professor Department of Immunology/ Microbiology Rush University Medical Center Chicago, Illinois HIV and Aging The introduceon
More informationC E L I A J. M A X W E L L, M. D
H I V / A I D S I N O L D E R I N D I V I D U A L S T H E G R A Y I N G O F T H E D I S E A S E E X T E N U A T I N G V S M I T I G A T I N G F A C T O R S C E L I A J. M A X W E L L, M. D., F A C P A
More informationImprovement of Quality of Life after the Application of Mindfulness-Based Cognitive Therapy in Subjects Aging with HIV Infection
Improvement of Quality of Life after the Application of Mindfulness-Based Cognitive Therapy in Subjects Aging with HIV Infection Carmina R. Fumaz HIV Unit-LLuita contra la Sida Foundation Germans Trias
More informationFuture challenges for clinical care of an ageing population infected with HIV: a geriatric -HIV modelling study
Future challenges for clinical care of an ageing population infected with HIV: a geriatric -HIV modelling study Guaraldi G 1, De Francesco D 2, Malagoli A 1, Theou O 3, Zona S 1, Carli F 1, Dolci G 1,
More informationMetabolic consequences of HIV-induced inflammation
Metabolic consequences of HIV-induced inflammation Jacqueline Capeau INSERM U938, Université Pierre et Marie Curie Faculté de Médecine, site Saint-Antoine, Hôpital Tenon, Paris, France 1. Pathogenesis
More informationHealthy Ageing with HIV
Healthy Ageing with HIV (It s More than Just Laboratory Values) Barcelona October 19 th 2014 Margarita Robau Gassiot mrobau@clinic.ub.es Hospital Clínic Barcelona Outline/ Agenda 1. What is Ageing? 2.
More informationHIV Infection as a Chronic Disease. Howard Libman, MD Beth Israel Deaconess Medical Center Harvard Medical School
HIV Infection as a Chronic Disease Howard Libman, MD Beth Israel Deaconess Medical Center Harvard Medical School Role of Primary Care Approximately 50,000 patients are diagnosed with HIV infection annually
More informationOptimizing Health While Aging with HIV
Slide 1 Optimizing Health While Aging with HIV Todd T. Brown, MD, PhD Division of Endocrinology and Metabolism Johns Hopkins University Unfortunately, We are Not Slide 2 Immortal But How Do We Want to
More informationStroke in Human Immunodeficiency Virus (HIV) infected pa9ents
Stroke in Human Immunodeficiency Virus (HIV) infected pa9ents M. Nigo, A. Walker, D. Lucido, A. Shah, M. Skliut, D. Mildvan Beth Israel Medical Center, New York Introduc@on The associa@on of stroke and
More informationReport Back from CROI 2010
Report Back from CROI 2010 Conference on Retroviruses and Opportunistic Infections Edwin Charlebois, MPH PhD Associate Professor of Medicine Department of Medicine University of California, San Francisco
More informationPART IV! CLINICAL IMPLICATIONS
PART IV! CLINICAL IMPLICATIONS Background Biological link between HIV and aging paints a grim picture, however The benefits of ART strongly outweigh the risks associated with ongoing immune activation
More informationHIV & Cardiovascular Disease How worried should we be?
HIV & Cardiovascular Disease How worried should we be? David Alain Wohl, MD Associate Professor Site Leader, University of North Carolina AIDS Clinical Trials Unit at Chapel Hill Pre- Test The main driver
More informationHIV Infection in the Long-term Survivor (Older Patient)
HIV Infection in the Long-term Survivor (Older Patient) Howard Libman, MD Professor of Medicine, Harvard Medical School Beth Israel Deaconess Medical Center Boston, Massachusetts Learning Objectives Define
More informationESCMID Online Lecture Library. by author
Improving Patient Safety: the Neglected Impact of Age and Gender, ESCMID Postgraduate Technical Workshop HIV in men, women and elderly Juan Ambrosioni MD, PhD Content HIV in men and women: differences
More informationHIV & Aging: Evolving Clinical Considerations in the New Millennium
HIV & Aging: Evolving Clinical Considerations in the New Millennium Julian Falutz, MD, FRCP (C) Director, HIV Metabolic Clinic Immunodeficiency Treatment Centre Senior Physician Division of Geriatrics
More informationFrailty in Geriatric Trauma Pa1ents
Division of Trauma, Burn, Surgical Critical Care, & Emergency General Surgery Frailty in Geriatric Trauma Pa1ents Zara Cooper, MD, MSc, FACS Elizabeth Bryant, MPH Disclosures NIA R01AG044518 NCI R35CA197730
More informationFrailty: from Academic Definition to Clinical Applicability
Frailty: from Academic Definition to Clinical Applicability Associate Professor Ruth E. Hubbard October 26 th 2018 Objectives 1. Describe the development of frailty as a concept 2. Provide an overview
More informationFactors Associated with Limitations in Daily Activity Among Older HIV+ Adults
Factors Associated with Limitations in Daily Activity Among Older HIV+ Adults KM Erlandson, K Wu, R Kalayjian, S Koletar, B Taiwo, FJ Palella Jr, K Tassiopoulos and the A5322 Team Background Growing burden
More informationHow to Implement this Assessment in the Clinical Prac5ce?
5th Interna*onal Symposium on Neuropsychiatry HIV - - - Barcelona, May 24-25th, 2012 Neuropsychological Screening in HIV Infec6on: How to Implement this Assessment in the Clinical Prac5ce? Jose A. Muñoz-
More informationAgeing with HIV. Amsterdam Institute for Global Health and Development. University of Amsterdam The Netherlands
Ageing with HIV Peter Reiss Professor of Medicine Dept of Infectious Diseases, Tropical Medicine and Aids and Dept of Global Health Academic Medical Center Amsterdam Institute for Global Health and Development
More informationHIV and Ageing Challenges and Goals
HIV and Ageing Challenges and Goals Julian Falutz MD, FRCPC Associate Professor Director Comprehensive HIV-Aging Initiative Chronic Viral Illness Service & Division of Geriatrics McGill University Health
More informationThe Role of Aspirin in HIV & Aging: Pro-Standpoint
The Role of Aspirin in HIV & Aging: Pro-Standpoint Virginia Triant Massachusetts General Hospital 6 th International Conference on HIV and Aging October 6, 2015 None Disclosures Questions for Debate Should
More informationTop 10 Things to Know About the Older Patient With HIV Infection
Top 10 Things to Know About the Older Patient With HIV Infection Howard Libman, MD Professor of Medicine, Emeritus Harvard Medical School Beth Israel Deaconess Medical Center Boston, Massachusetts Learning
More informationHans Strijdom SA Heart Meeting November 2017
Hans Strijdom SA Heart Meeting November 2017 HIV-infection and ART, but not high sensitivity CRP, are associated with markers of vascular function: Results from the Western Cape cohort of the EndoAfrica
More information(n=6279). Continuous variables are reported as mean with 95% confidence interval and T1 T2 T3. Number of subjects
Table 1. Distribution of baseline characteristics across tertiles of OPG adjusted for age and sex (n=6279). Continuous variables are reported as mean with 95% confidence interval and categorical values
More informationHIV and Brain Func.on. Tristan J Barber Research Physician St Stephen s AIDS Trust Chelsea and Westminster Hospital
HIV and Brain Func.on Tristan J Barber Research Physician St Stephen s AIDS Trust Chelsea and Westminster Hospital HIV and the Brain When can HIV affect the brain? Seroconversion Long term infected (not
More informationJohn J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam
Latest Insights from the JUPITER Study John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam Inflammation, hscrp, and Vascular Prevention
More informationPrimary Care for Persons Living with HIV
Primary Care for Persons Living with HIV Brian Montague, DO MS MPH Assistant Professor of Medicine Division of Infectious Diseases Warren Alpert School of Medicine Brown University Outline What constitutes
More informationAll biomarkers at higher level in HIV group
Supplemental Table S1: Summary of studies assessing mainly inflammatory biomarkers and their association with mortality and clinical endpoints in HIV infection First author, year, country Biomarkers measured
More informationChronic complications of HIV infection. An update Pablo Tebas, MD
Activity Code TM809 Chronic complications of HIV infection. An update 2014 Pablo Tebas, MD Learning Objectives Upon completion of this presentation, learners should be better able to: Identify and update
More informationPrimary Care of the HIV-infected Adult: If I Can Do It, You Can Do It
Primary Care of the HIV-infected Adult: If I Can Do It, You Can Do It Howard Libman, MD Professor of Medicine, Emeritus Harvard Medical School Boston, Massachusetts Learning Objectives After attending
More informationAging and Cancer in HIV
Aging and Cancer in HIV Ronald Mitsuyasu, MD Professor of Medicine Director, UCLA Center for Clinical AIDS Research and Education Group Chairman, AIDS Malignancy Consortium (AMC) Age distribution of HIV-infected
More informationBlood biomarkers for the early diagnosis of dementia with Lewy bodies
Blood biomarkers for the early diagnosis of dementia with Lewy bodies Barcelona, 20 de octubre de 2015 Content 1. The Institution 2. The Product a) Target Indications b) The biomarkers c) Differential
More informationForget me not: providing care for people living with HIV and dementia (What does the future hold for our elderly HIV patients?)
Forget me not: providing care for people living with HIV and dementia (What does the future hold for our elderly HIV patients?) Dr Simon Rackstraw FRCP Medical Director, Mildmay Hospital, London Consultant
More informationHIV and Co-morbidities November 18, 2013, 3:10 pm Abstract Number 141
Low omega-3 index in erythrocytes is a risk factor for progression of atherosclerosis in people living with HIV Bianca M Arendt, M Smieja, IE Salit, DWL Ma, F Smaill, D Elston, E Lonn, Johane P Allard
More informationAging & HIV an unaddressed timebomb waiting to explode
Slide 1 Aging & HIV an unaddressed timebomb waiting to explode Jules Levin, NATAP National AIDS Treatment Advocacy Project www.natap.org Projected Proportion of those Living With HIV in United States 50+
More informationMulGple factors likely explain this increased risk, including co- morbid. condigons and angretroviral drug toxicity
HIV and Aging AIDS Patients Face Downside of Living Longer, January 2008 Many Age- associated Diseases Are More Common in Treated HIV Disease Than In Age- matched Uninfected Persons What causes atherosclerosis
More informationSarcopenia. Juan Jesús Carrero. Dept Medical Epidemiology and Biosta9s9cs Karolinska Ins9tutet, Sweden.
Sarcopenia Juan Jesús Carrero Dept Medical Epidemiology and Biosta9s9cs Karolinska Ins9tutet, Sweden. 1 Revisi&ng the concept of sarcopenia in geriatric diseases Nephrol Dial Transplant. 2017 Jul 1;32(7):1127-1136.
More informationPhysiology Unit 3 THE SPECIFIC IMMUNE RESPONSE
Physiology Unit 3 THE SPECIFIC IMMUNE RESPONSE The Adap4ve Arm of the Immune System Specific Immune Response Internal defense against a specific pathogen Acquired as you are exposed to diseases The immune
More informationNumber of cardiometabolic disorders increases with degree of frailty among people aging with HIV
Number of cardiometabolic disorders increases with degree of frailty among people aging with HIV Thomas D Brothers, Lindsay MK Wallace, Andrea Malagoli, Antonella Santoro, Olga Theou, Susan Kirkland, Kenneth
More informationD:A:D: Cumulative Exposure to DRV/r Increase MI Risk
D:A:D: Cumulative Exposure to DRV/r Increase MI Risk 20.0-15.0-10.0-5.0-4.0-3.0-2.0-1.0- Unadjusted CVD rate ratios per 5 years additional exposure: ATV/r 1.25 [1.10-1.43] and DRV/r 1.93 [1.63-2.28] Adjusted*
More informationHIV-1 Dual Infection and Neurocognitive Impairment
HIV-1 Dual Infection and Neurocognitive Impairment Gabriel Wagner, MD Assistant Professor of Medicine Infectious Diseases & Global Public Health UC San Diego HIV-Associated End Organ Damage Antiretroviral
More informationHormonal Contraception Use and Non-AIDSdefining
Hormonal Contraception Use and Non-AIDSdefining Events Vlada Melekhin, MD, MPH January 10, 2012 Vanderbilt University Outline Background Methods Results Conclusions Limitations Future Directions Hormonal
More informationFrailty Assessment: Simplifying the Complex
Frailty Assessment: Simplifying the Complex Natalie Sanders, DO Internal Medicine, Geriatrics Rocky Mountain Geriatrics Conference 2017 U N I V E R S I T Y O F U T A H H E A L T H, 2 0 1 7 OBJECTIVES Define
More informationThe purpose. What are some of the comorbidities MORE IMPORTANTLY ARE THEY REALLY RELATED TO HIV AT ALL
The purpose What are some of the comorbidities MORE IMPORTANTLY ARE THEY REALLY RELATED TO HIV AT ALL The answer Comorbidities exist need to be handled BUT relationship with HIV enormous implications for
More informationpublic health crisis! Understanding frailty at population level!
Frailty as an emerging public health crisis! Understanding frailty at population level! Dr Rónán O Caoimh, MB, MRCPI, MSc, PhD Senior Lecturer in Geriatric Medicine 08/03/2017 A brief history of frailty...
More informationImpact of Persistent Immune Activation in Treated HIV Infection
Impact of Persistent Immune Activation in Treated HIV Infection Peter W. Hunt, MD Associate Professor of Medicine in Residence UCSF/SFGH HIV/AIDS Division Life Expectancy * May Start to Approach General
More informationEpidemiologic Measure of Association
Measures of Disease Occurrence: Epidemiologic Measure of Association Basic Concepts Confidence Interval for population characteristic: Disease Exposure Present Absent Total Yes A B N 1 = A+B No C D N 2
More information50+ SHADES OF GREY, AGING WITH HIV
50+ SHADES OF GREY, AGING WITH HIV R E B E C C A G L A S S M A N, M D I N S T R U C T O R O F M E D I C I N E, H A R V A R D M E D I C A L S C H O O L MR. C 71 years old Diagnosed with HIV in 1998 at the
More informationNeurocogni*ve tes*ng and cochlear implanta*on: insights into performance in older adults
Neurocogni*ve tes*ng and cochlear implanta*on: insights into performance in older adults Maura K Cosetti 1 MD James B. Pinkston, PhD 1 ; Jose M. Flores, MPH, PhD 3 ; David R. Friedmann, MD 2 ; Callie B.
More informationFrailty. Nicholas Butler MD, MBA Department of Family Medicine University of Iowa
Frailty Nicholas Butler MD, MBA Department of Family Medicine University of Iowa Doris 84 yo female who comes into your clinic with her daughter. She complains of feeling increasingly fatigued and just
More informationEthical questions about biomarkers of ageing the view of geriatrics
Ethical questions about biomarkers of ageing the view of geriatrics Biomarker of Ageing Halle 18.-20.09.2009 Manfred Gogol, M.D. Coppenbrügge Definition Biomarker of Ageing (BMA) are agents that allows
More informationNutritional concerns of overweight / obese older persons. Gordon L Jensen, MD, PhD Dept Nutritional Sciences Penn State University
Nutritional concerns of overweight / obese older persons Gordon L Jensen, MD, PhD Dept Nutritional Sciences Penn State University Prevalence of obesity among older adults: NHANES 1999-2004 Sex Age (years)
More informationOutline. Epidemiology of Pediatric HIV 10/3/2012. I have no financial relationships with any commercial entity to disclose
Nutritional, Metabolic, and Gastrointestinal Complications in Pediatric HIV Infection Tracie L. Miller, MD Department of Pediatrics University of Miami, Miller School of Medicine I have no financial relationships
More informationFRAILTY SYNDROME. dr. Rose Dinda Martini, Sp.PD, K-Ger
FRAILTY SYNDROME dr. Rose Dinda Martini, Sp.PD, K-Ger Geriatric Division, Internal Medicine Department M. Djamil Hospital Padang Faculty of Medicine, Andalas University, 2018 Medical syndrome Multiple
More informationHIV: A Chronic Condition
JOURNAL OF INSURANCE MEDICINE Copyright E 2015 Journal of Insurance Medicine J Insur Med 2015;45:136 141 INSURABILITY FOR HIV INFECTED INDIVIDUALS HIV: A Chronic Condition Daniel D. Zimmerman, MD By virtue
More informationClinical Infectious Diseases Advance Access published June 16, Age-Old Questions: When to Start Antiretroviral Therapy and in Whom?
Clinical Infectious Diseases Advance Access published June 16, 2015 1 Age-Old Questions: When to Start Antiretroviral Therapy and in Whom? Rochelle P. Walensky, Martin S. Hirsch From the Division of Infectious
More informationAgeing with HIV. Moderator: Georg Behrens, Germany. Silvia Nozza, Italy Adrian Curran, Spain
Ageing with HIV Moderator: Georg Behrens, Germany Silvia Nozza, Italy Adrian Curran, Spain Italian Data from ISS In 2015 in Italy 650 new HIV infections occurred in people more than 50 years old Most of
More informationAutonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors
Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors Carmine Pizzi 1 ; Lamberto Manzoli 2, Stefano Mancini 3 ; Gigliola Bedetti
More informationDrug Side Effects That Mimic Aging
Drug Side Effects That Mimic Aging Darrell R. Abernethy, MD, PhD Associate Director for Drug Safety FDA PHARMACOKINETIC CHANGES IN THE ELDERLY Process Change with Age Drug Elimination Renal Elimination
More informationEventi cerebro-vascolari: davvero una nuova frontiera?
Eventi cerebro-vascolari: davvero una nuova frontiera? Leonardo Calza Clinica di Malattie Infettive, Policlinico S.Orsola-Malpighi, Università di Bologna (Lancet 2016) Changes in leading 30 causes of death,
More informationChairs: John Lainchbury & Andrew Aitken. Elderly/Frailty
Frailty Elderly/Frailty Ralph Stewart Chairs: John Lainchbury & Andrew Aitken Elderly/Frailty Ralph Stewart Green Lane Cardiovascular Service and Cardiovascular Research Unit Auckland City Hospital 1 What
More informationGDF-15 levels but not NTproBNP levels predict diastolic heart failure in morbid obesity
GDF-15 levels but not NTproBNP levels predict diastolic heart failure in morbid obesity M. Fischer, C. Strack, J. Bruxmeier, F. Wagner, E. Rousseva, G. Schmitz, G. Riegger, A. Baessler Clinic for Internal
More informationMortalité et Morbidité à l ère des traitements antirétroviraux dans les Pays du Nord
Mortalité et Morbidité à l ère des traitements antirétroviraux dans les Pays du Nord Laurence WEISS Hôpital Européen Georges Pompidou, Université Paris-Descartes Paris, France Deaths per 100 Person-Years
More informationCardiovascular Complications of HIV and Its Treatment
Cardiovascular Complications of HIV and Its Treatment FORMATTED: 11/6/15 Marshall J. Glesby, MD, PhD Professor of Medicine, Healthcare Policy and Research Weill Cornell College of Medicine New York, New
More informationHIGH BURDEN OF METABOLIC COMORBIDITIES IN A CITYWIDE COHORT OF HIV OUTPATIENTS
HIGH BURDEN OF METABOLIC COMORBIDITIES IN A CITYWIDE COHORT OF HIV OUTPATIENTS Evolving Health Care Needs of People Aging with HIV in Washington, DC Matthew E. Levy 1, Alan E. Greenberg 1, Rachel Hart
More informationAppendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors.
Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors. Appendix to: Banks E, Crouch SR, Korda RJ, et al. Absolute risk of cardiovascular
More informationThe Immune Aspects of HIV Malignancy, Aging, and End- Organ Disease
The Immune Aspects of HIV Malignancy, Aging, and End- Organ Disease Peter W. Hunt, MD Assistant Professor of Medicine UCSF HIV/AIDS Division Disclosures Research Grant Support Roche, Pfizer, Salix Consulting
More informationPATIENTS AND METHODS:
BACKGROUND: Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease characterized by erosive synovitis that involves peripheral joints and implicates an important influence in the quality
More informationIntegrating Geriatrics into Oncology Care
Integrating Geriatrics into Oncology Care William Dale, MD, PhD Chief, Geriatrics & Palliative Medicine Director, Specialized Oncology Care & Research in the Elderly (SOCARE) Clinic University of Chicago
More informationThe Metabolic Syndrome: Is It A Valid Concept? YES
The Metabolic Syndrome: Is It A Valid Concept? YES Congress on Diabetes and Cardiometabolic Health Boston, MA April 23, 2013 Edward S Horton, MD Joslin Diabetes Center Harvard Medical School Boston, MA
More informationProspective Evaluation of the Eyeball Test for Assessing Frailty in Elderly Patients with Valvular Heart Disease
Prospective Evaluation of the Eyeball Test for Assessing Frailty in Elderly Patients with Valvular Heart Disease Background Frailty is a common occurrence in elderly patients Approximately half of the
More informationReasons why we will never forget. Andrea Antinori INMI L. Spallanzani IRCCS, Roma
Reasons why we will never forget Andrea Antinori INMI L. Spallanzani IRCCS, Roma SMRs according to time spent with CD4 count >500/mm3 after cart initiation in MSM 80,642 HIV-infected individuals eligible
More informationTestosterone Therapy in Men An update
Testosterone Therapy in Men An update SANDEEP DHINDSA Associate Professor of Medicine Director, Division of Endocrinology and Metabolism, Saint Louis University, St. Louis, MO Presenter Disclosure None
More informationNeurocognitive impairment and cardiovascular disease
Neurocognitive impairment and cardiovascular disease Andrea De Luca, M.D. Professor of Infectious Diseases Director, post-graduate schoolof Infectiousand TropicalDiseases, University of Siena Director,
More informationDidactic Series. Non-Infectious Complications of HIV. Ankita Kadakia, MD UC San Diego, Owen Clinic November 8, 2018
Didactic Series Non-Infectious Complications of HIV Ankita Kadakia, MD UC San Diego, Owen Clinic November 8, 2018 1 Disclosures The following presenter have disclosed the following relationship with a
More informationSarcopenia una definicion en evolucion. Hélène Payette, PhD Centre de recherche sur le vieillissement
Sarcopenia una definicion en evolucion Hélène Payette, PhD Centre de recherche sur le vieillissement X Curso ALMA Cancun, Mexico, Julio 2011 NIA conference Epidemiologic and Methodologic Problems in Determining
More informationLGBT Aging: HIV Prevention and Primary Care for LGBT Older Adults
LGBT Aging: HIV Prevention and Primary Care for LGBT Older Adults Jonathan S. Appelbaum, MD, FACP, AAHIVS Associate Professor and Education Director, Internal Medicine Florida State University College
More information